Neuromuscular Ultrasound in ALS
| Status: | Completed |
|---|---|
| Conditions: | Neurology, ALS |
| Therapuetic Areas: | Neurology, Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 11/8/2014 |
| Start Date: | February 2013 |
| End Date: | June 2014 |
Ultrasonography in Amyotrophic Lateral Sclerosis as a Predictor of Disease Progression and Tool in Diagnosis: a Pilot Study
Amyotrophic Lateral Sclerosis (ALS) is a progressive fatal neurodegenerative disease
affecting motor neurons. Early diagnosis is essential for the success of clinical trials and
objective biomarkers are needed for monitoring disease progression. Nerve and muscle
ultrasound may provide this information.
This study will collect pilot data to evaluate the value of muscle and nerve ultrasound to
identify and monitor disease progression in ALS.
affecting motor neurons. Early diagnosis is essential for the success of clinical trials and
objective biomarkers are needed for monitoring disease progression. Nerve and muscle
ultrasound may provide this information.
This study will collect pilot data to evaluate the value of muscle and nerve ultrasound to
identify and monitor disease progression in ALS.
Inclusion Criteria:
- Subjects referred to the electromyography laboratory for ALS.
Exclusion Criteria:
- Patients with known comorbid myopathy or neuropathy will be excluded from the study.
- Patients unable to provide their own consent will be excluded.
We found this trial at
1
site
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials
